CBH UG

Germany

At CBH UG, our strength lies in the passion, expertise, and dedication of our people. The team behind our success is a dynamic group of scientists, researchers, industry experts, and innovators committed to advancing biomedical research through reliable and ethical biospecimen sourcing. Our ...

Gearbox Biosciences

Estonia

Antibiotic-free protein production: Our Pop-Out-PlasmidTM Technology allows to produce recombinant proteins in E. coli without any selection marker (antibiotic-free) and without adding an inducer like IPTG. As a plus, our technology decouples growth and production stages.

Humify GmbH

Germany

Humify has developed a breakthrough process to convert biomass into artificial humic substances. The efficiency of this continuous process enables scaling up on a global scale to restore fertile soils with significantly increased carbon sequestration. The production and application of Humify ...

Deep MedChem a.s.

Czechia

AI-Powered Drug Discovery for Medicinal & Computational Chemists through our flagship CHEESE platform. Our flagship CHEESE Molecular Search (Chemical Embeddings Search Engine) transforms virtual high-throughput screening (vHTS). It screens billions of compounds (Enamine REAL, Chemriya or your ...

Cytocast

Hungaria

Cytocast is a data-driven biotechnology company, providing a cell simulation platform, that can revolutionize how we treat patients starting from drug discovery and development (Cytocast Digital Twin Cell™) to selecting the best treatment option for patients (Cytocast Digital Twin Patient™).

Toleris Biotherapeutics GmbH

Germany

Founded in January 2024, Toleris Biotherapeutics is a pioneering biotech company based in Würzburg, Germany. Led by an experienced team of scientists and entrepreneurs, we specialize in developing first-in-class AutoImmunity Modifying Biologics (AIM Bios) - a breakthrough therapeutic approach ...

Synendos Therapeutics AG

Switzerland

Synendos Therapeutics AG is a biopharmaceutical company founded in April 2019 as a spin-off of the University of Bern. Synendos develops an innovative therapeutic approach based upon first-in-class inhibitors (small molecules) that modulate a new drug target (not yet published). The inhibitors ...

QuantView GmbH

Germany

Since its spin-off from Kiel University in 2025, Germany, QuantView has been conducting applied research with numerous renowned research partners in Germany and abroad on the practical further development of Metabolic Resonance Imaging. We are using our own patented, advanced “PHIP plus” ...

Nuclidium AG

Switzerland

NUCLIDIUM AG is a clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer. Leveraging copper isotopes – Copper-61 for diagnostics and Copper-67 for therapeutics – NUCLIDIUM is creating a ...

Neoclease

USA

Neoclease is a biotechnology company pioneering AI-designed gene-editing therapies optimized for individual genes. Using a proprietary platform that integrates generative protein models with synthetic biology, Neoclease builds ultra-precise, delivery-ready nucleases for diseases with high unmet ...